ADMA Biologics Investors Should Contact Block & Leviton to Possibly Recover Losses Through The Firm's InvestigationNewsfile Corp • 05/11/26
$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost MoneyGlobeNewsWire • 05/11/26
ROSEN, LEADING INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMANewsfile Corp • 05/08/26
$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered LossesGlobeNewsWire • 05/08/26
ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics InvestorsNewsfile Corp • 05/07/26
ADMA Biologics Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Possibly Recover LossesNewsfile Corp • 05/07/26
BREAKING: ADMA Biologics Shares Fall Over 24%; Investors Encouraged to Contact Block & Leviton to Possibly Recover LossesGlobeNewsWire • 05/06/26
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 05/06/26
$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to ActGlobeNewsWire • 05/06/26
Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?Zacks Investment Research • 05/05/26
Andrew Sather: Why Some Stock Buybacks Are Basically “Putting Money on Fire”24/7 Wall Street • 05/04/26
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and OlderGlobeNewsWire • 05/04/26
$ADMA Stock Drop Alert: ADMA Biologics Stock Plummeted 29% on News of Channel Stuffing – Investors Notified to Contact BFA Law about its InvestigationGlobeNewsWire • 05/04/26
Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending InvestigationGlobeNewsWire • 05/01/26
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewsWire • 04/30/26
$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA LawGlobeNewsWire • 04/29/26
ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA LawGlobeNewsWire • 04/27/26
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?Zacks Investment Research • 04/24/26
ADMA Legal Notification: ADMA Biologics Securities Class Action Investigation Ongoing – Investors with Losses after 29% Stock Drop Notified to Contact BFA LawGlobeNewsWire • 04/24/26